# ZNF429

## Overview
ZNF429 is a gene that encodes the zinc finger protein 429, a member of the zinc finger protein family known for its role in DNA binding and transcriptional regulation. The protein is characterized by zinc finger motifs, which are structural domains that facilitate its interaction with DNA, allowing it to function primarily as a transcription factor. Zinc finger protein 429 is involved in various cellular processes, including cell differentiation and proliferation, by modulating the transcription of target genes. Although the specific functions of ZNF429 in normal cellular physiology are not fully elucidated, it has been implicated in the modulation of drug responses and is associated with genetic variations influencing pain management and pharmacogenomics (Kim2009GenomeWide; Squassina2019Zinc). Additionally, ZNF429 has clinical significance in psychiatric disorders and cancer, where it may serve as a biomarker for treatment efficacy and play a role in disease pathogenesis (Pisanu2018Convergent; Micci2010Array‐CGH).

## Structure
ZNF429, or zinc finger protein 429, is a member of the zinc finger protein family, characterized by the presence of zinc finger domains that facilitate DNA binding. The primary structure of ZNF429 is rich in cysteine and histidine residues, which are crucial for forming the zinc finger motifs. These motifs are essential for the protein's ability to interact with DNA.

The secondary structure of ZNF429 typically includes alpha helices and beta sheets, which contribute to the stability and functionality of the zinc finger domains. The tertiary structure involves the folding of these motifs into a stable configuration, allowing the protein to maintain its functional conformation.

Post-translational modifications such as phosphorylation and ubiquitination can influence the function of ZNF429. These modifications may alter the protein's activity, stability, or interactions with other molecules. Additionally, splice variants of ZNF429 may lead to different isoforms, each potentially having distinct functions. These isoforms can result from alternative splicing events, which may affect the protein's role in cellular processes.

The quaternary structure of ZNF429 may involve interactions with other proteins, although specific details about these interactions are not provided in the available context.

## Function
ZNF429 (zinc finger protein 429) is a member of the zinc finger protein family, which is characterized by the presence of zinc finger motifs that facilitate binding to DNA. These proteins often function as transcription factors, regulating gene expression by binding to specific DNA sequences. ZNF429 is involved in various cellular processes, including cell differentiation and proliferation, by modulating the transcription of target genes. It is typically active in the nucleus, where it influences the expression of genes critical for maintaining normal cellular functions.

The specific function of ZNF429 in healthy human cells is not well-characterized. However, it is known to be involved in the regulation of gene expression through its role as a transcription factor. ZNF429 has been implicated in the modulation of responses to various treatments, such as lithium in bipolar disorder and imatinib mesylate in gastrointestinal stromal tumors, suggesting its involvement in cellular pathways that affect drug response (Rink2013ZNFMediated; Squassina2019Zinc). Additionally, ZNF429 has been associated with genetic variations that influence individual responses to analgesic drugs and post-surgical pain, indicating its potential role in pain management and pharmacogenomics (Kim2009GenomeWide).

## Clinical Significance
ZNF429 has been implicated in various clinical conditions, particularly in psychiatric disorders and cancer. In the context of bipolar disorder, ZNF429 has been associated with the response to lithium treatment. Studies integrating genome-wide genotyping and transcriptomic data have identified ZNF429 as significantly associated with lithium response in patients with bipolar disorder, suggesting its potential role as a biomarker for treatment efficacy (Pisanu2018Convergent; Squassina2019Zinc).

In cancer research, ZNF429 has been identified in chromosome 19 gains in ovarian carcinomas. The overexpression or rearrangement of zinc finger genes, including ZNF429, may play a significant role in the pathogenesis of ovarian cancer. These genetic alterations could contribute to carcinogenesis by affecting the expression of oncogenes or tumor suppressor genes (Micci2010Array‐CGH).

While the specific functions of ZNF429 remain uncharacterized, its involvement in these conditions highlights the importance of further research to understand its role in disease mechanisms and potential therapeutic implications. The findings suggest that alterations in ZNF429 expression or mutations could be significant in both psychiatric and oncological contexts.


## References


[1. (Kim2009GenomeWide) Hyungsuk Kim, Edward Ramsay, Hyewon Lee, Sharon Wahl, and Raymond A Dionne. Genome-wide association study of acute post-surgical pain in humans. Pharmacogenomics, 10(2):171–179, February 2009. URL: http://dx.doi.org/10.2217/14622416.10.2.171, doi:10.2217/14622416.10.2.171. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.2217/14622416.10.2.171)

[2. (Micci2010Array‐CGH) Francesca Micci, Rolf I. Skotheim, Lisbeth Haugom, Jörg Weimer, Anne Mette E. Eibak, Vera M. Abeler, Claes G. Trope, Norbert Arnold, Ragnhild A. Lothe, and Sverre Heim. Array‐cgh analysis of microdissected chromosome 19 markers in ovarian carcinoma identifies candidate target genes. Genes, Chromosomes and Cancer, 49(11):1046–1053, August 2010. URL: http://dx.doi.org/10.1002/gcc.20813, doi:10.1002/gcc.20813. This article has 18 citations.](https://doi.org/10.1002/gcc.20813)

[3. (Rink2013ZNFMediated) Lori Rink, Michael F. Ochs, Yan Zhou, Margaret von Mehren, and Andrew K. Godwin. Znf-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor. PLoS ONE, 8(1):e54477, January 2013. URL: http://dx.doi.org/10.1371/journal.pone.0054477, doi:10.1371/journal.pone.0054477. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0054477)

[4. (Pisanu2018Convergent) Claudia Pisanu, Donatella Congiu, Marta Costa, Caterina Chillotti, Raffaella Ardau, Giovanni Severino, Andrea Angius, Urs Heilbronner, Liping Hou, Francis J. McMahon, Thomas G. Schulze, Maria Del Zompo, and Alessio Squassina. Convergent analysis of genome‐wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177(7):658–664, October 2018. URL: http://dx.doi.org/10.1002/ajmg.b.32663, doi:10.1002/ajmg.b.32663. This article has 10 citations.](https://doi.org/10.1002/ajmg.b.32663)

[5. (Squassina2019Zinc) Alessio Squassina, Anna Meloni, Caterina Chillotti, and Claudia Pisanu. Zinc finger proteins in psychiatric disorders and response to psychotropic medications. Psychiatric Genetics, 29(5):132–141, October 2019. URL: http://dx.doi.org/10.1097/ypg.0000000000000231, doi:10.1097/ypg.0000000000000231. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/ypg.0000000000000231)